Bone cancer pain is a complex process with many potential targets for therapeutic intervention. As pain is the most common presenting symptom in patients with skeletal metastases and is directly proportional to the patient’s quality of life, clinical advancements in the treatment of bone cancer pain are of the utmost importance. Research targeting pain-related cytokines, anti-osteoclastic medications, and ion channels has shown significant clinical progress in the treatment of cancer-related bone pain. With continued efforts into these and other therapeutic strategies, we hope to continue to improve the quality of life of those patients suffering with bone cancer pain.
|Original language||English (US)|
|Title of host publication||Metastatic Bone Disease|
|Subtitle of host publication||An Integrated Approach to Patient Care|
|Publisher||Springer New York|
|Number of pages||8|
|State||Published - Jan 1 2015|
Bibliographical notePublisher Copyright:
© Springer Science+Business Media New York 2016.
- Bone cancer
- Ion channels
- Skeletal metastasis